Joseph J. Romano
Chief Executive Officer
Mr. Romano has worked with Michael and Selim Zilkha in the energy industry since 1989. Mr. Romano was President and Chief Executive Officer of Zilkha Renewable Energy and Senior Vice President and Chief Financial Officer of Zilkha Energy Company.
He presently serves as Chairman of the Board of Contango Oil and Gas (NYSE: MCF), President and CEO of Olympic Energy Partners, and director and Vice President of Laetitia Vineyard & Winery. He served as Chief Financial Officer, Treasurer, and Controller of Texas International Company from 1986 to 1988 and as its Treasurer and Controller from 1982 to 1985.
Prior to 1982, Mr. Romano spent five years working in the Worldwide Energy Group of the First National Bank of Chicago.
He earned a BA in economics and political science from the University of Wisconsin in Eau Claire and an MBA from the University of Northern Illinois.
Kent E. Pryor, PhD, MBA
Chief Operating Officer
Dr. Pryor joined the company full-time in 2010 to coordinate drug development operations including manufacturing, quality systems, regulatory affairs, and clinical research.
Previously, he served as Chief Operating Officer of SynthRx, Inc., Associate Director of Drug Development at Kémia, Inc., and Group Leader at Corvas International, Inc. Dr. Pryor has served on the Boards of Directors for multiple non-profit corporations and currently serves on the Advisory Board of Assay Depot.
Dr. Pryor received his BA in chemistry magna cum laude from Rice University, a PhD in organic chemistry from the Massachusetts Institute of Technology, and an MBA from the Rady School of Management at the University of California, San Diego.
Craig M. Van De Mark, JD
Mr. Van De Mark served as General Counsel to Zilkha Biomass Energy from 2005 until June 2008, and also served as General Counsel to Zilkha Renewable Energy from 1998 to 2005 and Zilkha Energy Company from 1994 to 1996.
He also worked with Sterling Consulting Group providing strategy consulting to Fortune 500 energy companies for two years, and was previously in private legal practice for several years with a national law firm.
Mr. Van De Mark earned a BBA degree in finance from the University of Texas at Austin and a JD degree cum laude from the University of Houston,
where he served on the Houston Law Review and was elected to the Order of the Coif.
He is a licensed attorney in the State of Texas and he has an “AV” peer review rating from Martindale-Hubbell.
Frank Del Greco, MBA
Director of Clinical Program Management
Mr. Del Greco joined the company in 2016 to plan and oversee the clinical development programs of 3K3A-APC. He has been working in the clinical research industry since 1997 and has expertise in all aspects of clinical trial management, with over 10 years of project management experience. He has worked with a variety of companies within clinical research, including small biotech, mid-large size pharma, and CRO’s, and has extensive global clinical research experience.
Mr. Del Greco earned a BA in Biology from Denison University and an MBA from Fairleigh Dickinson University.
Mr. Hennock has over 25 years in corporate advisory services with Citibank, Bank of America and Jacanda Capital.
He founded Access Systems, which was sold to International Gaming Technology Inc in 1999. He was a Director and CFO of Nuon Therapeutics Inc, and a co-founder and CEO of Bioatrix Pty Ltd. which was acquired by ZZ Biotech, LLC in 2015.
He earned a BEc from the University of Sydney.
Tadeusz Wellisz, MD
Dr. Wellisz is the Chairman of Ceremed, Inc. and co-founder and Chairman of Bioplate, Inc. At the time of founding Bioplate in 1993, he was Chief of Plastic and Reconstructive Surgery at Rancho Los Amigos Medical Center.
Dr. Wellisz received a BA in biology from the University of Chicago and an MD from the Columbia University College of Physicians and Surgeons. He did surgical residency at the New York University School of Medicine and plastic surgery residency at the University of Southern California.